Walleye Trading’s Vera Therapeutics VERA Stock Holding History

Walleye Trading’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,500	Closed	-$43.6K	–	4854
2025 Q3	$43.6K	Buy	+1,500	New	+$34.7K	﹤0.01%	3996

Other funds holding VERA

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Walleye Trading's VERA Position: Q4 2025 in Review

Walleye Trading sold out of Vera Therapeutics (VERA) in Q4 2025, closing a stake of 5,225 shares — an estimated $152K sold.

Walleye Trading first reported a position in VERA in Q4 2022 and held it in 2 quarters. The position peaked at $212K in Q4 2022. 214 funds tracked by Wall St. Rank hold VERA as of Q4 2025.

Walleye Trading reported no remaining Vera Therapeutics position as of Q4 2025 after selling out during the quarter.
Walleye Trading sold 5,225 Vera Therapeutics shares in Q4 2025, an estimated $152K.
Walleye Trading first reported a position in Vera Therapeutics in Q4 2022 and held it in 2 quarters.
Walleye Trading's Vera Therapeutics position peaked at $212K in Q4 2022.
214 funds tracked by Wall St. Rank held Vera Therapeutics as of Q4 2025.

Based on Walleye Trading's 13F filing for Q4 2025, filed 13 Feb 2026.